Briefing Report for Council of Secretaries: Project: PROMETHEUS
Classification: Top Secret
Project Objective: Artificially improve the human genome
Project Brief: In 1963, China developed the technology necessary to clone human beings. In [EXPUNGED], [EXPUNGED] successfully acquired intact cloning and neural imprinting apparatuses from Green and Red Chinese sources. [EXPUNGED] authorized Project: PANDORA, the reverse-engineering and analysis of this captured technology. Project: PANDORA discovered that Chinese cloning technology is essentially "black box" in nature - the Chinese have minimal understanding of the human genome and merely clone samples of genetic material with no understanding of how the genetics in question work. Project: PANDORA suggests that Chinese personnel known as "Jiang-Shi" are the result of this imperfect cloning. In [EXPUNGED], Project: PROMETHEUS was authorized to sequence the human genome and, using techniques derived from Chinese technology, assess the viability of artificially editing the human genetic code.
Results: Project: PROMETHEUS was divided into several task forces with different objectives. Results are as follows.
Task Force One: Sequence the human genome.
Results: Complete success. Results are classified, but PROMETHEUS has complete knowledge of the human genetic code.
Task Force Two: Assess potential for genetic alteration.
Results: Complete success. Using technology derived from Chinese cloning, deliberate alteration of the human genetic structure and production of altered individuals is possible.
Task Force Three: Artificial disease resistance
Results: Success. Proto-clones displayed immune systems an order of magnitude more efficient than standard. Better than seventy percent success rate resisting multiple strains of anthrax, ebola, and human immunodeficiency virus. Better than eighty percent success rate preventing genetic disorders such as sickle-cell anemia.
Task Force Four: Genetic retroengineering
Results: Complete failure. Attempts to alter genetic structure of adults in random tests at selected hospitals in North America, South America, and Europe resulted in zero percent success rate and irreparable genetic damage to subjects (see attached report). Alterations of genetic structure in fetuses resulted in sixty percent failure rate. However, successes lead to unexpected complications: the mother's body rejects the altered fetus, resulting in one hundred percent rate of miscarriage.
Task Force Five: Improved human capability
Results: Partial success. Attempts at wide spectrum improvement of traits including but not limited to sense acuity, muscle and bone density and mass, reflexes, and intelligence suffered eighty percent failure across the board. Specific successes are detailed in attached report, but include development of complete night vision and major increases in circulatory and respiratory system efficiency.
Project Conclusions: Artificial improvement of human genome possible but presently impractical. Improved subjects must be created via cloning or artificial wombs (see Project: VENUS). Alteration of current population impossible via purely genetic alteration. Second-stage physiological alterations (implants, neurochemical treatments, etc) required for further improvement. Synergetic effects with genetic engineering possible.